A citation-based method for searching scientific literature

Kate Dunlop, Nicole M Rankin, Amelia K Smit, Zofia Salgado, Ainsley J Newson, Louise Keogh, Anne E Cust. Health Expect 2021
Times Cited: 3







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
125
100

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.
Pamela M Marcus, Nora Pashayan, Timothy R Church, V Paul Doria-Rose, Michael K Gould, Rebecca A Hubbard, Michael Marrone, Diana L Miglioretti, Paul D Pharoah, Paul F Pinsky,[...]. Cancer Epidemiol Biomarkers Prev 2016
37
66

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.
Chris Degeling, Alexandra Barratt, Sanchia Aranda, Robin Bell, Jenny Doust, Nehmat Houssami, Jolyn Hersch, Ruben Sakowsky, Vikki Entwistle, Stacy M Carter. BMJ Open 2018
9
66

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
26
66

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
20
66


Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
35
66

Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.
Juliet A Usher-Smith, Laragh L W Harvey-Kelly, Sabrina H Rossi, Hannah Harrison, Simon J Griffin, Grant D Stewart. Health Expect 2021
6
66

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
66
33

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
Jennifer G Walker, Finlay Macrae, Ingrid Winship, Jasmeen Oberoi, Sibel Saya, Shakira Milton, Adrian Bickerstaffe, James G Dowty, Richard De Abreu Lourenço, Malcolm Clark,[...]. Trials 2018
7
33

The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening
Grace Y Kim, Jennifer G Walker, Adrian Bickerstaffe, Nadira Hewabandu, Marie Pirotta, Louisa Flander, Mark Jenkins, Jon D Emery. Aust J Gen Pract 2018
9
33


Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.
Enola Proctor, Hiie Silmere, Ramesh Raghavan, Peter Hovmand, Greg Aarons, Alicia Bunger, Richard Griffey, Melissa Hensley. Adm Policy Ment Health 2011
33


European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders. BMC Cancer 2020
9
33

Effect of interventions including provision of personalised cancer risk information on accuracy of risk perception and psychological responses: A systematic review and meta-analysis.
Max Bayne, Madi Fairey, Barbora Silarova, Simon J Griffin, Stephen J Sharp, William M P Klein, Stephen Sutton, Juliet A Usher-Smith. Patient Educ Couns 2020
5
33

Identification of cancer risk and associated behaviour: implications for social marketing campaigns for cancer prevention.
Rebecca Kippen, Erica James, Bernadette Ward, Penny Buykx, Ardel Shamsullah, Wendy Watson, Kathy Chapman. BMC Cancer 2017
9
33

Consumer and clinician perspectives on personalising breast cancer prevention information.
L A Keogh, E Steel, P Weideman, P Butow, I M Collins, J D Emery, G B Mann, A Bickerstaffe, A H Trainer, L J Hopper,[...]. Breast 2019
11
33

Resisting Moralisation in Health Promotion.
Rebecca C H Brown. Ethical Theory Moral Pract 2018
15
33


Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.
Alex T Ramsey, Li-Shiun Chen, Sarah M Hartz, Nancy L Saccone, Sherri L Fisher, Enola K Proctor, Laura J Bierut. Transl Behav Med 2018
8
33

Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis.
Simon Chapman, Kim McLeod, Melanie Wakefield, Simon Holding. Med J Aust 2005
127
33

Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?
Sujha Subramanian, Georgiy Bobashev, Robert J Morris, Sonja Hoover. Cancer Causes Control 2017
12
33

Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit.
Monika Janda, Anne E Cust, Rachel E Neale, Joanne F Aitken, Peter D Baade, Adele C Green, Kiarash Khosrotehrani, Victoria Mar, H Peter Soyer, David C Whiteman. Aust N Z J Public Health 2020
13
33

Implementation considerations for offering personal genomic risk information to the public: a qualitative study.
Amelia K Smit, Gillian Reyes-Marcelino, Louise Keogh, Kate Dunlop, Ainsley J Newson, Anne E Cust. BMC Public Health 2020
5
33

The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Amelia K Smit, Ainsley J Newson, Rachael L Morton, Michael Kimlin, Louise Keogh, Matthew H Law, Judy Kirk, Suzanne Dobbinson, Peter A Kanetsky, Georgina Fenton,[...]. Contemp Clin Trials 2018
10
33

Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework.
Mandeep Sekhon, Martin Cartwright, Jill J Francis. BMC Health Serv Res 2017
675
33

A response to "Personalised medicine and population health: breast and ovarian cancer".
Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, Mireille Broeders, Jennifer Brooks, Anna Chiarelli, Jocelyne Chiquette, Jack Cuzick, Suzette Delaloge, Peter Devilee,[...]. Hum Genet 2019
11
33

Stratified cancer screening: the practicalities of implementation.
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
38
33

Communicating genetic risk information for common disorders in the era of genomic medicine.
Denise M Lautenbach, Kurt D Christensen, Jeffrey A Sparks, Robert C Green. Annu Rev Genomics Hum Genet 2013
91
33

Protocol and Rationale for the International Lung Screening Trial.
Kuan Pin Lim, Henry Marshall, Martin Tammemägi, Fraser Brims, Annette McWilliams, Emily Stone, Renee Manser, Karen Canfell, Marianne Weber, Luke Connelly,[...]. Ann Am Thorac Soc 2020
23
33



Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Linda Rainey, Daniëlle van der Waal, Yvonne Wengström, Anna Jervaeus, Mireille J M Broeders. Acta Oncol 2018
13
33

Risk-based breast cancer screening strategies in women.
Elaine F Harkness, Susan M Astley, D Gareth Evans. Best Pract Res Clin Obstet Gynaecol 2020
18
33

Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
18
33

"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.
Jocelyn Lippey, Louise A Keogh, G Bruce Mann, Ian G Campbell, Laura E Forrest. Cancer Prev Res (Phila) 2019
13
33

Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey.
Markus Dines Knudsen, Geir Hoff, Ida Tidemann-Andersen, Gry Ekeberg Bodin, Sissel Øvervold, Paula Berstad. J Cancer Educ 2021
4
33

Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.
Marianne F Weber, Henry M Marshall, Nicole Rankin, Stephen Duffy, Kwun M Fong, Kate Dunlop, Lauren Humphries, Amelia K Smit, Anne E Cust, Natalie Taylor,[...]. Public Health Res Pract 2019
3
33

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
Amelia K Smit, Ainsley J Newson, Megan Best, Caro-Anne Badcock, Phyllis N Butow, Judy Kirk, Kate Dunlop, Georgina Fenton, Anne E Cust. Eur J Hum Genet 2018
14
33

What is overdiagnosis and why should we take it seriously in cancer screening?
Stacy M Carter, Alexandra Barratt. Public Health Res Pract 2017
20
33

Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information.
James F O'Mahony, Joost van Rosmalen, Ann G Zauber, Marjolein van Ballegooijen. Med Decis Making 2013
12
33

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
Yuki Tomonaga, Kevin Ten Haaf, Thomas Frauenfelder, Malcolm Kohler, Roger D Kouyos, Mohaned Shilaih, Matthias Lorez, Harry J de Koning, Matthias Schwenkglenks, Milo A Puhan. Lung Cancer 2018
27
33

Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Stephen Wade, Marianne Weber, Michael Caruana, Yoon-Jung Kang, Henry Marshall, Renee Manser, Shalini Vinod, Nicole Rankin, Kwun Fong, Karen Canfell. J Thorac Oncol 2018
21
33

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.
A E Hall, S Chowdhury, N Hallowell, N Pashayan, T Dent, P Pharoah, H Burton. J Public Health (Oxf) 2014
31
33


Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D P Pharoah, Nora Pashayan. PLoS Med 2019
32
33

Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings.
Iakovos Toumazis, Emily B Tsai, S Ayca Erdogan, Summer S Han, Wenshuai Wan, Ann Leung, Sylvia K Plevritis. JNCI Cancer Spectr 2019
15
33

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
27
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.